The U.S. Government is renewing its focus on mitigating technological risks by regulating the supply chain for various goods and services. To achieve these goals, Congress and agencies have introduced, and in some cases enacted, legislation and regulations that direct agencies to identify, assess, and mitigate supply chain risks generally as well as prohibit agencies
The future of the Border Adjustment Tax (BAT) proposal, a critical element of the House Republican tax reform plan, is in doubt after signs of Republican opposition in the Senate emerged last week. Senator David Perdue (R-GA) became the most prominent Republican to overtly criticize the BAT, expressed in a Dear Colleague letter to his
January has already proven an eventful month for developers of small modular reactors (SMRs) and non-light water (i.e., advanced) reactors.
After failing to pass a TRIA reauthorization during the lame duck session last Congress, on January 7, 2015, the House passed H.R. 26, the Terrorism Risk Insurance Program Reauthorization Act of 2015, by a vote of 416-5. Shortly after on January 8, 2015, the Senate passed H.R. 26 by a 93-4 vote. Upon the President’s signature, TRIA will be reauthorized until December 31, 2020.
Twenty years ago, two years after the first inauguration of President Clinton, Republicans took control of both houses of Congress for the first time since 1953. Despite significant disagreements between Clinton and the Republican-controlled Congress, that period of 1995 through 2000 was a relatively productive one for the U.S. Congress, producing welfare reform, several tax bills, a balanced budget agreement, significant telecommunications legislation, and many other laws.
One of the challenges facing regulators as they craft rules to govern the Internet of Things is that traditional industry silos that were the basis for past legislation may no longer apply. As part of the 2014 Winnik Forum, Hogan Lovells’ partners Michele Farquhar and Trey Hanbury joined two senior staff members from the U.S.
Last evening, House and Senate staff released a new legislative proposal that reflects their negotiated agreement on how to clarify the Food and Drug Administration’s (FDA) authority to regulate compounding pharmacies. The legislation will resolve the 1st Amendment and severability issues relating to section 503A of the Food, Drug and Cosmetic Act. These issues have